Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting

Background: Currently available topical treatments for actinic keratosis (AK) adversely affect patients’ quality of life because of long treatment durations and long-lasting local skin reactions (LSRs), which may result in poor treatment adherence and patient outcomes. Ingenol mebutate gel, a recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Michael, Erntoft, Sandra, Persson, Sofie, Norlin, Jenny M., Persson, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2014
Materias:
Dermatological Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341863/
https://www.ncbi.nlm.nih.gov/pubmed/34430663
http://dx.doi.org/10.36469/9879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341863/
https://www.ncbi.nlm.nih.gov/pubmed/34430663
http://dx.doi.org/10.36469/9879

Ejemplares similares